CANNA HEMP X - Trademark Details
Status: 661 - Response After Non-Final Action - Entered
Image for trademark with serial number 88984136
Serial Number
88984136
Word Mark
CANNA HEMP X
Status
661 - Response After Non-Final Action - Entered
Status Date
2022-04-25
Filing Date
2018-11-05
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
BAGLINI, KAREN
Statements
Goods and Services
Dietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Dietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Medicated lip balm, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Medicated lip balm, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Orally-ingestible medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of dietary or nutritional supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Orally-ingestible medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of dietary or nutritional supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-11-20
Primary Code
005
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Thomas F. Zuber
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Continuity Parent88979268
Trademark Events
Event DateEvent Description
2018-11-08NEW APPLICATION ENTERED IN TRAM
2018-11-09TEAS VOLUNTARY AMENDMENT RECEIVED
2018-11-09TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
2018-11-20NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-11-25ASSIGNED TO EXAMINER
2019-06-19ASSIGNED TO EXAMINER
2019-06-19NON-FINAL ACTION WRITTEN
2019-06-19NON-FINAL ACTION E-MAILED
2019-06-19NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-08-08TEAS WITHDRAWAL OF ATTORNEY RECEIVED
2019-08-08WITHDRAWAL OF ATTORNEY GRANTED
2019-08-08TEAS CHANGE OF CORRESPONDENCE RECEIVED
2019-12-18TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2019-12-18ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-12-19TEAS REQUEST TO DIVIDE RECEIVED
2019-12-19TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-01-13ASSIGNED TO LIE
2020-01-14CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-01-17CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-01-17TEAS/EMAIL CORRESPONDENCE ENTERED
2019-12-19DIVISIONAL REQUEST RECEIVED
2020-01-23DIVISIONAL PROCESSING COMPLETE
2020-01-23DIVISIONAL PROCESSING COMPLETE
2020-02-20NON-FINAL ACTION WRITTEN
2020-02-20NON-FINAL ACTION E-MAILED
2020-02-20NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-08-19TEAS REQUEST TO DIVIDE RECEIVED
2020-08-19TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-08-19CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-08-20TEAS/EMAIL CORRESPONDENCE ENTERED
2020-08-19DIVISIONAL REQUEST RECEIVED
2020-08-25DIVISIONAL PROCESSING COMPLETE
2020-10-08TEAS REQUEST TO DIVIDE RECEIVED
2020-10-08TEAS VOLUNTARY AMENDMENT RECEIVED
2020-10-08PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
2020-10-08DIVISIONAL REQUEST RECEIVED
2020-10-14DIVISIONAL PROCESSING COMPLETE
2020-11-12NON-FINAL ACTION WRITTEN
2020-11-12NON-FINAL ACTION E-MAILED
2020-11-12NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-02-23TEAS CHANGE OF OWNER ADDRESS RECEIVED
2021-02-23TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-02-23ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-02-23TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-02-23APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2021-05-10TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-05-10CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-05-11TEAS/EMAIL CORRESPONDENCE ENTERED
2021-05-24ASSIGNED TO EXAMINER
2021-10-13ASSIGNED TO EXAMINER
2021-10-21NON-FINAL ACTION WRITTEN
2021-10-21NON-FINAL ACTION E-MAILED
2021-10-21NOTIFICATION OF NON-FINAL ACTION E-MAILED
2022-04-20TEAS REQUEST TO DIVIDE RECEIVED
2022-04-20TEAS RESPONSE TO OFFICE ACTION RECEIVED
2022-04-20CORRESPONDENCE RECEIVED IN LAW OFFICE
2022-04-25TEAS/EMAIL CORRESPONDENCE ENTERED
2022-04-20DIVISIONAL REQUEST RECEIVED
2022-04-25DIVISIONAL PROCESSING COMPLETE